NUS scientists discover novel vulnerabilities in dengue virus

March 30, 2017

A team of researchers from the National University of Singapore (NUS) has uncovered hidden vulnerabilities on the surface of the dengue virus. This novel discovery means that scientists can now develop strategies to target these weak spots for treatment of dengue, and possibly other closely related diseases like Zika, influenza and chikungunya.

Led by Associate Professor Ganesh S Anand from the Department of Biological Sciences at the NUS Faculty of Science, the 9-member research team published their findings in the prestigious scientific journal Nature Communications on 10 February 2017.

New treatment possibilities for the highly infectious and deadly disease

Dengue fever, caused by the dengue virus transmitted by the Aedes mosquito, is a serious global healthcare challenge which sees approximately 390 million infections annually. In Singapore, more than 13,000 people were infected in 2016, and nine deaths had resulted from the virus in that year. While a vaccine against the virus is recently available commercially, its effectiveness is limited as it is not effective against all the four dengue viral subtypes, and there are no alternative therapeutics yet.

To block the viral outbreaks, the NUS research team, which also comprises Professor Thorsten Wohland, Associate Professor Lok Shee-Mei, Dr Arun Chandramohan and Mr Lim Xin-Xiang, sought to identify new approaches to tackle the dengue virus.

The team monitored the changes that the dengue virus undergo in three different conditions, namely: when it is inside the Aedes mosquito, when it is inside a healthy human, and when it is inside a patient suffering from dengue fever. When the dengue virus is transmitted to a healthy person, the change in the temperature of the host - from 28 degree Celsius in a mosquito to 37 degree Celsius in a human body - causes the virus to swell by 20 per cent. This expansion exposes weak spots on the surface of the virus that were previously hidden.

Lead researcher Assoc Prof Ganesh explained, "When the dengue virus is outside the human host, several of its surface regions are tucked away within a compact soccer ball-like arrangement. When the virus enters a human host, it senses an increase in temperature and puffs up to reveal new surfaces. This is a very exciting discovery as it offers numerous possibilities of designing therapies and vaccines to target these exposed surfaces to treat dengue as well as other related viruses such as Zika and chikungunya. Our team will be working towards this goal."
-end-


National University of Singapore

Related Dengue Fever Articles from Brightsurf:

Researchers validate rapid tests to detect dengue, Zika, yellow fever and other viruses
The method identifies and distinguishes between flaviviruses that cause many diseases in humans and animals in Brazil.

Breakthrough on curbing dengue
Scientists from Australia's national science agency, CSIRO, and the University of California San Diego have engineered the first breed of genetically modified mosquitoes resistant to spreading all four types of the dengue virus.

Mosquitoes engineered to repel dengue virus
An international team of scientists has synthetically engineered mosquitoes that halt the transmission of the dengue virus.

Cellular culprit suspected of pushing dengue fever from bad to worse is cleared by transcripts
No one knows what makes a mild dengue viral infection morph into a severe and sometimes deadly dengue hemorrhagic fever/dengue shock syndrome.

Forecasting dengue: Challenges and a way forward
International collaboration is finding new ways to improve how scientists develop and test models to forecast dengue infection.

Anemia may contribute to the spread of dengue fever
Mosquitoes are more likely to acquire the dengue virus when they feed on blood with low levels of iron, researchers report in the 16 September issue of Nature Microbiology.

People's initial immune response to dengue fever analyzed
Researchers have come one step closer to understanding how our immune system responds to acute dengue fever, a disease that has affected hundreds of thousands of people in Southeast Asia this summer alone.

Possible treatment on the horizon for severe dengue disease
New study reveals enzyme plays key role in potentially fatal dengue haemorrhagic fever and shock; suggests clinically approved tryptase inhibitor could be key in future targeted treatment.

A new picture of dengue's growing threat
New research shows the expanded risk of dengue virus infection through 2080, with detailed maps for 2020, 2050 and 2080.

Shedding light on the burden of dengue in Bangladesh
Dengue, also known as dengue fever, is a viral disease transmitted to humans by mosquitoes of the genus Aedes.

Read More: Dengue Fever News and Dengue Fever Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.